Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06048185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study

Study acronym: SUSTAIN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Enrolling by Invitation to Active, Not Recruitingv5
  2. Re-verified, no change to tracked fieldsv4
  3. Start date changed from estimate of Oct 2023 to Oct 19, 2023v3
  4. Start date: Sep 2023 to Oct 2023v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current study is a non-interventional long-term safety follow-up of the subjects who completed STARLIGHT, in accordance with FDA guidance on recipients of human gene therapy products.
Trial Details
NCT Number NCT06048185
Lead Sponsor Nanoscope Therapeutics Inc.
Conditions
(from sponsor)		 Stargardt Disease
Related terms Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, Retinal Dystrophies, Stargardt Disease
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov